Expression and Clinical Significance of IL-17 and IL-17 Receptor in Ulcerative Colitis

Overview

Journal J Huazhong Univ Sci Technolog Med Sci

Specialty General Medicine

Date 2016 Feb 4

PMID 26838737

Citations 6

Authors

Heng Zhang

Bing Xia

Jin Li

Qiu Zhao

Zhi-Tao Chen

Rui Zhou

Jie Wu

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to determine the expression levels of IL-17 in serum and IL-17 receptor (IL-17R) in intestinal mucosa tissue in patients with ulcerative colitis (UC) and controls, and evaluate their relationship with disease activity and explore the role of IL-17 in the patho-genesis of UC. A total of 36 Chinese UC patients and 60 healthy controls were enrolled in this study. Serum IL-17 and C-reactive protein (CRP) levels were determined by ELISA and immunonephelometry, respectively. The IL-17R mRNA expression levels were detected by quantitative PCR. Serum IL-17 levels were significantly elevated in UC patients as compared with those in the healthy controls (P<0.05). Among UC patients, serum IL-17 levels were significantly increased in active phase as compared with those in inactive phase (P<0.05), and correlated with CRP levels (r=0.578, P<0.01). IL-17R expression levels were higher in active UC patients than in healthy controls (P<0.05). It was concluded that IL-17 levels were highly expressed in UC, especially in active phase, and correlated with CRP levels in UC patients.

Citing Articles

Molecular analyses of ADAMTS-1, -4, -5, and IL-17 a cytokine relationship in patients with ulcerative colitis.

Buran T, Batir M, Cam F, Kasap E, Collu F, Celebi H BMC Gastroenterol. 2023; 23(1):345.

PMID: 37798683 PMC: 10552413. DOI: 10.1186/s12876-023-02985-z.

Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome.

Zhai L, Yang W, Li D, Zhou W, Cui M, Yao P J Pharm Pharm Sci. 2023; 26:11225.

PMID: 37305432 PMC: 10248730. DOI: 10.3389/jpps.2023.11225.

Analysis of the Efficacy and Pharmacological Mechanisms of Action of Zhenren Yangzang Decoction on Ulcerative Colitis Using Meta-Analysis and Network Pharmacology.

Xing G, Zhang Y, Wu X, Wang H, Liu Y, Zhang Z Evid Based Complement Alternat Med. 2022; 2021:4512755.

PMID: 34992665 PMC: 8727130. DOI: 10.1155/2021/4512755.

Epstein-Barr Virus DNA Exacerbates Colitis Symptoms in a Mouse Model of Inflammatory Bowel Disease.

Andari S, Hussein H, Fadlallah S, Jurjus A, Shirinian M, Hashash J Viruses. 2021; 13(7).

PMID: 34210024 PMC: 8310145. DOI: 10.3390/v13071272.

Based on Network Pharmacology to Explore the Molecular Targets and Mechanisms of Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis.

Wei M, Li H, Li Q, Qiao Y, Ma Q, Xie R Biomed Res Int. 2020; 2020:5217405.

PMID: 33299870 PMC: 7710413. DOI: 10.1155/2020/5217405.

References

Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S . IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol. 2006; 177(1):566-73. DOI: 10.4049/jimmunol.177.1.566. View

Strober W, Fuss I, Mannon P . The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007; 117(3):514-21. PMC: 1804356. DOI: 10.1172/JCI30587. View

Satsangi J, Silverberg M, Vermeire S, Colombel J . The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55(6):749-53. PMC: 1856208. DOI: 10.1136/gut.2005.082909. View

Fuss I, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S . Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest. 2004; 113(10):1490-7. PMC: 406524. DOI: 10.1172/JCI19836. View

Rao D, Eid R, Qin L, Yi T, Kirkiles-Smith N, Tellides G . Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection. J Exp Med. 2008; 205(13):3145-58. PMC: 2605225. DOI: 10.1084/jem.20081661. View

Andoh A, Yagi Y, Shioya M, Nishida A, Tsujikawa T, Fujiyama Y . Mucosal cytokine network in inflammatory bowel disease. World J Gastroenterol. 2008; 14(33):5154-61. PMC: 2744005. DOI: 10.3748/wjg.14.5154. View

Korn T, Bettelli E, Oukka M, Kuchroo V . IL-17 and Th17 Cells. Annu Rev Immunol. 2009; 27:485-517. DOI: 10.1146/annurev.immunol.021908.132710. View

Yang X, Chang S, Park H, Nurieva R, Shah B, Acero L . Regulation of inflammatory responses by IL-17F. J Exp Med. 2008; 205(5):1063-75. PMC: 2373839. DOI: 10.1084/jem.20071978. View

Rovedatti L, Kudo T, Biancheri P, Sarra M, Knowles C, Rampton D . Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut. 2009; 58(12):1629-36. DOI: 10.1136/gut.2009.182170. View

10.

Hovhannisyan Z, Treatman J, Littman D, Mayer L . Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology. 2010; 140(3):957-65. PMC: 3049831. DOI: 10.1053/j.gastro.2010.12.002. View

11.

Oikonomou K, Kapsoritakis A, Kapsoritaki A, Manolakis A, Tiaka E, Tsiopoulos F . Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease. Inflamm Bowel Dis. 2010; 17(4):963-70. DOI: 10.1002/ibd.21410. View

12.

Fuss I, Neurath M, Boirivant M, Klein J, de La Motte C, Strong S . Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996; 157(3):1261-70. View

13.

Elson C, Cong Y, Weaver C, Schoeb T, McClanahan T, Fick R . Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology. 2007; 132(7):2359-70. DOI: 10.1053/j.gastro.2007.03.104. View

14.

OConnor Jr W, Kamanaka M, Booth C, Town T, Nakae S, Iwakura Y . A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. 2009; 10(6):603-9. PMC: 2709990. DOI: 10.1038/ni.1736. View

15.

Vincent F, Northcott M, Hoi A, Mackay F, Morand E . Clinical associations of serum interleukin-17 in systemic lupus erythematosus. Arthritis Res Ther. 2013; 15(4):R97. PMC: 3979031. DOI: 10.1186/ar4277. View

16.

Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y . Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2002; 52(1):65-70. PMC: 1773503. DOI: 10.1136/gut.52.1.65. View

17.

Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls J . Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis. 2006; 12(5):382-8. DOI: 10.1097/01.MIB.0000218764.06959.91. View

18.

Shih D, Targan S . Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol. 2008; 14(3):390-400. PMC: 2679127. DOI: 10.3748/wjg.14.390. View

19.

Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, Saito R . IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut. 2008; 57(12):1682-9. DOI: 10.1136/gut.2007.135053. View

20.

Kaser A, Zeissig S, Blumberg R . Inflammatory bowel disease. Annu Rev Immunol. 2010; 28:573-621. PMC: 4620040. DOI: 10.1146/annurev-immunol-030409-101225. View